StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.54−0.50 (-5.53%)

Close on Nov 16, 2026Market cap $297.90MP/E –Yield –

Benitec Biopharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Benitec Biopharma's EV/EBITDA was 165.0× on Jul 31, 2020.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2020Jul 31, 2020165.0×−12.2
2019Dec 31, 2019177.2×–

More Benitec Biopharma figures

See a number that looks wrong?